03-0078-00
SMC® Bead-Based Immunoassay Development Buffer Kit
Synonym(s):
SMC® Assay Development Kit, Single Molecule Counting Assay Development Kit, ultra-sensitive Assay Development Kit
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
manufacturer/tradename
SMC®
Quality Level
technique(s)
ELISA: suitable
single molecule counting: suitable
Related Categories
General description
Take advantage of SMC® proprietary technology while developing your own application-specific immunoassays in bead format. This kit provides everything you need to build your own high performing SMC® immunoassay. It includes buffers, reagents, and optimized protocol for bead-based assay development. The reagents are suitable for up to 30 Bead-based assays.
Application
SMC® Bead-Based Immunoassay Development Buffer Kit has been used to perform Singulex assay.
Components
Discovery Standard Diluent
Discovery Assay Buffer
10X Wash Buffer
Elution Buffer B
Buffer D
Discovery Assay Buffer
10X Wash Buffer
Elution Buffer B
Buffer D
Other Notes
Create application-specific immunoassays in bead format and move beyond the traditional ELISA with SMC® technology.
For use with the single molecule counting SMC® systems.
For use with the single molecule counting SMC® systems.
Legal Information
SMC is a registered trademark of Singulex
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial
signalword
Danger
hcodes
Hazard Classifications
Aquatic Chronic 3 - Eye Irrit. 2 - Repr. 1B - Skin Sens. 1
wgk_germany
WGK 3
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Journal of immunological methods, 491, 112995-112995 (2021-02-15)
Human immunodeficiency virus (HIV) remains a significant public health issue. In recent years, passive immunization with broadly neutralizing antibodies (bNabs) is being considered as a potentially efficacious approach for fighting HIV. One candidate that holds great promise is represented by
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service